-transparent.png){kind=logo}
The effects of multiple doses of ofloxacin 200 mg, ciprofloxacin 250 mg or enoxacin 400 mg (all twice daily) on the pharmacokinetic properties of single doses of caffeine (220 to 230 mg) were investigated in 12 healthy volunteers. Intraindividual comparisons showed that ciprofloxacin and enoxacin significantly inhibited the elimination of caffeine. Ofloxacin, however, did not affect any of the measured pharmacokinetic properties of caffeine. Thus, caffeine should be avoided in patients with liver disorders, cardiac arrhythmias, latent epilepsy or in intensive care while undergoing treatment with enoxacin or ciprofloxacin.
Related Publications
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
August 1986,
Medizinische Klinik (Munich, Germany : 1983),
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
August 1994,
Journal of clinical psychopharmacology,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
January 1988,
The Journal of asthma : official journal of the Association for the Care of Asthma,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
July 2001,
Diagnostic microbiology and infectious disease,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
March 1989,
Clinical pharmacology and therapeutics,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
October 1995,
Journal of clinical psychopharmacology,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
October 1991,
Clinical pharmacology and therapeutics,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
January 2002,
Neuropsychobiology,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
February 2005,
Biophysical chemistry,
A H Staib, and
W Stille, and
G Dietlein, and
P M Shah, and
S Harder, and
S Mieke, and
C Beer
May 1999,
General pharmacology,
